v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash $ 324,000 $ 325,000
Trade accounts receivable, net 1,091,000 1,957,000
Other receivables 32,000 99,000
Inventory, net 2,160,000 1,665,000
Prepaid expenses and other current assets 194,000 182,000
Total current assets 3,801,000 4,228,000
Property, plant and equipment, net of depreciation 8,658,000 8,297,000
Intangible assets, net of amortization 125,000 125,000
Other non-current assets 139,000 180,000
Total assets 12,723,000 12,830,000
Current liabilities:    
Line of credit 167,000 1,124,000
Accounts payable - trade 1,595,000 3,086,000
Accounts payable - construction in progress 1,818,000 2,433,000
Disputed co-manufacturer accounts payable (Note 5) 499,000 499,000
Accrued expenses 349,000 388,000
Accrued payroll and employee related expenses 187,000 173,000
Financing agreements - current 285,000 296,000
Notes payable 441,000 3,031,000
Total current liabilities 5,341,000 11,030,000
Financing agreements 480,000 470,000
Convertible notes 6,986,000
Total liabilities 12,807,000 11,500,000
Commitments and contingencies
Stockholders’ (deficit) equity:    
Preferred stock, $0.000001 par value, 400,000 shares authorized, none issued or outstanding
Common stock, $0.000001 par value; 35,000,000 shares authorized; and 16,208,160 and 15,969,281 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid in capital 68,753,000 67,645,000
Accumulated deficit (68,837,000) (66,315,000)
Total stockholders’ (deficit) equity (84,000) 1,330,000
Total liabilities and stockholders’ (deficit) equity $ 12,723,000 $ 12,830,000